Usa state California San Francisco, state California covid-19 reports patient Usa state California San Francisco, state California

Study: Azithromycin doesn't prevent COVID-19 symptoms in outpatients

Reading now: 572

A single dose of the broad-spectrum antibiotic azithromycin didn't change the proportion of US COVID-19 patients reporting symptoms by 14 days, finds a randomized, controlled trial published late last week in JAMA.The study, led by University of California at San Francisco (UCSF) researchers, involved assigning 263 non-hospitalized adult COVID-19 patients to either a 1.2-gram dose of oral azithromycin (171) or a placebo (92) from May 2020 to March 2021.Participants, who had tested positive for COVID-19 within the past 7 days, were followed for as many as 21 days to gauge whether the antibiotic would prevent disease progression by 14 days.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News